|
49% Decrease in Cardiovascular
Disease Deaths in
High Risk Women with Vitamin E
JAMA , July 2005
May 21, 2007
In the July 2005 journal of the American Medical Association, known
as JAMA, there was a study published called the Women’s Health Study.
This study revealed the results of the largest and longest vitamin E
trial in history.
The study consisted of:
• |
39,876 apparently healthy US women aged 45 years and over. |
• |
Women were randomly assigned either esterified vitamin E, placebo, or aspirin or placebo. |
• |
Women were followed for 10 years. The results showed that vitamin E use resulted in a significant 24% reduction in all cardiovascular events. |
• |
Women 65 years or over comprised 10% of the study subjects, but contributed 31% of the end points. |
• |
Women 65 years or older are at highest risk for CVD. |
Why is this important? Women in the highest risk percentile for Cardiovascular Disease (women age 65 and over) saw a 34% decrease in heart attacks and an incredible 49% decrease in Cardiovascular deaths.
These results are even more dramatic when you realize that the women were only taking 600 I.U.of esterified alpha tocopheryl every other day!
Results Not Covered,
Just Covered Up
Amazingly, the authors of the study somehow concluded that vitamin E
had no benefit. And the resulting headlines were, "Study finds
vitamin E has no benefit in women." "Vitamin E fails again."
The fantastic results seen in highest-risk women were not only hidden
by the authors of the study, they managed to marginalize the significant
24% decrease in CVD events in all women, to conclude that vitamin E
had no benefit—a conclusion that contradicted their findings.
Like clockwork, the fact that aspirin had no benefit seemed to evade the researchers and the media.
|
|||||||
